chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Employee received the vaccine around 1130.  She was monitored for a least 30 minutes due to her history of CA and Immunosupressed state.  She went back to her office post monitoring.  Around 1535, one of her employees called reporting that she didn't look good and was acting weird - pale; stumbling; slurred speech.  The coworker brought employee to the immunization clinic in private vehicle.  Dr. along with the CNE and another RN went to the vehicle to asses.  It was noted that employee did have slurred/slow speech; droopiness to face.  She reported that she started to not feel well while in her office.  V/S: B/P 141/102; pulse 108; O2 sat 96% on RA; skin pale.  She stated that she felt "loopy".  Employees husband was called and her co-worker was instructed to take the employee to the ER where her husband would meet them.  At 1540, employee was taken to ER for evaluation.
I have chronic urticara that is triggered by the cold, sweat, and pressure on my skin (pinch, poke, etc.)
Information has been received from a health professional concerning a female who on 11-MAR-1999 was vaccinated with a dose of Varivax (Oka/Merck) (Lot# 627875/1245H). Subsequently the patient experienced rash of less than 50 lesions. The event was not documented/evaluated by a medical doctor. Follow-up information was received that indicated that there was no further information on this patient. Additional information is not expected.
Patient was given Pfizer vaccine as dose #2 after he reported receiving Pfizer initially. We later found out he received Moderna as dose #1, about 6mos prior to today's dose #2.
it's making my body not fighting of anything else; I have to go to ER, it was that bad; I had my 3rd Booster; I broke out with shingles; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 66-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; Unknown manufacturer), for Covid-19 Immunization; Shingles vaccine. The following information was reported: HUMORAL IMMUNE DEFECT (medically significant), outcome "unknown", described as "it's making my body not fighting of anything else; I have to go to ER, it was that bad"; HERPES ZOSTER (non-serious), outcome "unknown", described as "I had my 3rd Booster; I broke out with shingles". The events "it's making my body not fighting of anything else; i have to go to er, it was that bad" and "i had my 3rd booster; i broke out with shingles" required emergency room visit. The patient underwent the following laboratory tests and procedures: Lab Work: Unknown results. Therapeutic measures were taken as a result of humoral immune defect, herpes zoster.  Clinical course: Nurse stated that the patient got her shingles vaccine (Further name could not be clarified hence, suspect captured as Unspecified vaccine) so, she should not have gotten the shingles and she thought that they are saying that it's by having the third booster, it made her body not fighting of anything else. So, she has to go to ER, it was that bad. She did not have liver issues because they had to give me antiviral drugs (Intent: Treatment) because of the shingles.  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Tested positive for COVID-19 on 02/06/2023 and had a televisit with my primary care physician on 02/07/2023. My doctor prescribed PAXLOVID. My symptoms were very mild including a scratchy throat and felt feverish on the second night. Beyond that, I had essentially no symptoms. Symptoms were gone within 3 or 4 days. I tested negative on 02/14/2023.
I had extreme exhaustion with dizziness when I would get up, slight congestion but no cough. No appetite. Initially I had nausea and slept a lot on the first couple of days. After 2 days I contacted the doctor and was prescribed antibiotic, nausea medication and pain medication. I took the 10 day dose of the Z-PAK. After the Z-PAK was done I still was unwell and testing positive for COVID-19, so I was placed on a different antibiotic and prednisone. The second round of antibiotic kicked the virus out of my system. I tested positive until around the 12/15th of July. I would say I was sick for almost 21 days, as a results I have a stress test scheduled.
(R) thigh area of erythema is 2 cm in diameter, warm to touch.
After receiving vaccine the next am pt developed large amount of swelling in right arm, size of "baseball", temp 103, severe headache and back pain.
This report was received from manf and was assigned manf report number A0524880A. Information has been received by the consumer who is a 30 year old female who on 21Jun04 was vaccinated with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy included a first dose of hep A virus vaccine inactivated (+) hep B virus vaccine rHBsAg (yeast) (Twinrix) and tetanus toxoid adsorbed. On 28Jun04, approx seven days following the first administration of hep A virus vaccine inactivated (+) hep B virus vaccine rHBsAg (yeast) (Twinrix), the pt developed hair loss and itching. The pt was seen at a physician's office and was treated with corticosteroids and desloratadine (Clarinex). The hair loss continued. The itching improved. On 23Jul04, the pt received the second dose of hep A virus vaccine inactivated (+) hep B virus vaccine rHBsAg (yeast) (Twinrix). The pt reported that the hair loss continued following the second dose of hep A virus vaccine inactivated (+) hep B virus vaccine rHBsAG (yeast) (Twinrix). The outcome was not recovered. The pt declined to grant authority to contact her physician; therefore, no further information will be available. No further information was provided.
Sharp pain in left arm and hand. Difficulty moving arm or using arm/hand to support weight (i.e. carrying items, getting dressed, etc).
I'm having very bad chills I got the vaccine yesterday; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (I'm having very bad chills I got the vaccine yesterday) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (I'm having very bad chills I got the vaccine yesterday). At the time of the report, CHILLS (I'm having very bad chills I got the vaccine yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant  medications  were reported. No treatment information  was provided.   Reporter did not allow further contact
Patient called pharmacist 2 days after receiving the Fluad and Shingrix vaccines to report that she developed a red, raised, and slightly warm red patch on her upper arm approximately 24 hours after being vaccinated.  This was the same arm in which she received the vaccines.  The spot was not painful and did not particularly bother her aside from the intermittent itching. Patient said she was not experiencing any signs on anaphylaxis and would continue to monitor. She believes it had improved since the day before.
Caller stated that she received her second Pfizer vaccine on 04/19/2021 and on the sameday she developed fever, the second day she developed migraine headache to the left of her head and on the third day she developed mouth sores.
InInitial misuse report received from a nurse on 14 October 2013. The patient had received FLUZONE HD. The patient was given expired FLUZONE HD from MDV. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender. None.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that, there was no power outages that would have impacted the Moderna vaccine. However, the healthcare professional reiterates that because her facility was unable to download the digital data logger, they needed to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment at this time. It was also reported that, no adverse reactions were reported by the patient.  No treatment medication was provided.
On 02/28/2023 I started feeling unwell and noticed that I had developed a boil that was painful to the point where I couldn't sit down.On 02/29/2023 I noticed that more boils had developed in the same area and was feeling sick.On 03/01/2023 I had a fever off and on and was able to see the Dermatologist. He prescribed a topical pain cream and referred me to the ER. I went to the ER and was put on a 24 hour antibiotic IV. I went home feeling better Saturday but was progressively feeling sick again. I went to the ER and again was put on a course of antibiotics and I developed a rash throughout my entire body. I stopped taking antibiotics and was put agin on Benadryl and prescribed Cefdinir 300 mgs.I am feeling better now however I will need to follow up with my Doctor.
A physician reported that a 21 month old male received his 2nd injection of Prevnar on 7/12/00. Two days, post vax, he developed an urticarial rash, which resolved after 48 hours. This is 1 of 2 pts from this facility who developed urticaria following receipt of Prevnar.
Information has been received from 73 years old male patient concerning on himself with no drug reactions or allergies. On October 2012, reported as "1-2 weeks ago", the patient was vaccinated with a dose of ZOSTAVAX (lot number, route and expiration date not provided). No other co-suspects were reported. Concomitant medications included simvastatin (manufacturer unknown), omeprazole, hydrochlorothiazide (manufacturer unknown), sertraline hydrochloride, finasteride (manufacturer unknown) and metoprolol. Past drug therapy included a flu shot vaccine one week before he received the ZOSTAVAX vaccine. On approximately 05-NOV-2012, "reported as noticed within the last 3 days", the patient developed pink spot with red dots in the area at his ZOSTAVAX injection site. The patient stated that as the injection site reaction began to heal, the patient noticed that he had larger spots developed on his back that were large somewhat itchy and scattered. No treatment information was given. Laboratory was performed through yearly check up. The patient did not seek medical attention. At the time of the report, the outcome of the events of pink spot with red dots in the area at his ZOSTAVAX injection site and larger spots developed on his back that are large somewhat itchy and scattered was reported as not recovered. The relatedness for pink spot with red dots in the area at his ZOSTAVAX injection site and larger spots developed on his back that are large somewhat itchy and scattered were unknown for ZOSTAVAX. Additional information has been requested.
pt admitted with covid pneumonia, resp failure.  placed on bipap, eventually grew dependent, comfort care given.
Developed diffuse rash/hives on scalp/chest neck/arm - more predominate on (L) side near injection site. Occurred 3 days after 1 last year same issue.
Husband had his 1st dose of the Moderna Covid-19 Vaccine in April but has not gotten the 2nd dose; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Husband had his 1st dose of the Moderna Covid-19 Vaccine in April but has not gotten the 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Husband had his 1st dose of the Moderna Covid-19 Vaccine in April but has not gotten the 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Husband had his 1st dose of the Moderna Covid-19 Vaccine in April but has not gotten the 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported.  No treatment medication were reported.
Pt. presented with vomiting and abdominal pain 8/19/07-taken to ER was later admitted to hospital-found to have a small bowel obstruction, not corrected by barium enema, needed to be taken to surgery (Dx: Intussusception) discharged on 8/22/07-all resolved.   9/4/2007 MR rceived from PCP including vax record and hospital D/C summary and labs.  Vax record c/w VAERS report.  Infant presented 8/20/07 with 1 day hx of decreased feeding, decreased UO, and 3 episodes of NBNB emesis.  Abdominal tenderness (+). Contrast enema showed IS but was could not be fully reduced.  Taken to OR for Open reduction with incidental appendectomy.  Discharged home on POD#2. Diagnosis:  Intussusception.
Facial numbness and tingling in addition to lip and tongue swelling. Left eyelid became droopy. Swelling did not obstruct airway.
second dose of vaccine on 01Apr2021, ER 2613 has given her what feels like lump under left arm still there on 05Apr2021; This is a spontaneous report from a contactable consumer (patient).   A 58-year-old non pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: ER2613), via an unspecified route of administration, administered in right arm on 01Apr2021 (at age of 58-year-old) as dose 2, single for covid-19 immunization. The patient was not pregnant at time of vaccination. Medical history included iodine allergy, egg allergy. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Concomitant medications included vitamin A (VITAMIN A [RETINOL]) taken for an unspecified indication, start and stop date were not reported, vitamin c [ascorbic acid] taken for an unspecified indication, start and stop date were not reported, vitamin D3 taken for an unspecified indication, start and stop date were not reported (within 2 weeks of vaccination). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration, administered in right arm on 03Mar2021 at 15:00 (at age of 58-year-old) as dose 1, single for covid-19 immunization and experienced kaleidoscope vision in right eye lasting about an hour a mild headache for 24 hours. The patient did not usually get headache. On an unspecified date in Apr2021, the patient reported that second dose of vaccine on 01Apr2021, ER 2613 has given her what feels like lump under left arm still there on 05Apr2021. The patient did not received treatment for the event. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
nose is running (nothing bad, but more than usual); Hoarse throat; 99.7° temperature yesterday (21Dec2021) and 99.8° today (22Dec2021); This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (nose is running (nothing bad, but more than usual)), DYSPHONIA (Hoarse throat) and PYREXIA (99.7° temperature yesterday (21Dec2021) and 99.8° today (22Dec2021)) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 016C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (hospitalized/needed rehab) in March 2020. Concurrent medical conditions included Stroke since August 2020.   On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Dec-2021, the patient experienced PYREXIA (99.7° temperature yesterday (21Dec2021) and 99.8° today (22Dec2021)). On an unknown date, the patient experienced RHINORRHOEA (nose is running (nothing bad, but more than usual)) and DYSPHONIA (Hoarse throat). At the time of the report, RHINORRHOEA (nose is running (nothing bad, but more than usual)), DYSPHONIA (Hoarse throat) and PYREXIA (99.7° temperature yesterday (21Dec2021) and 99.8° today (22Dec2021)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Dec-2021, Body temperature: 99.7 (High) 99.7 degree temperature. On 22-Dec-2021, Body temperature: 99.8 (High) 99.8 degree.         No relevant concomitant medications were reported.  No treatment information was provided.    Reporter did not allow further contact
3/14/07 Had Menactra vaccine, right arm given IM. Today mom brought child in because of large red, warm to touch, 6 cm area on right arm. Advised to give Benadryl, Tylenol, warm compresses. Return to clinic if worse.
Child noted to have numerous bruises all over his body that were not explainable by any injury. He was seen by the pediatrician two that following monday and his platelets were noted to be at 45. He was referred to a hematologist and diagnosed with ITP and his platelets droppped to 5.  He was admitted to the hospital and needed and infusion of IGG on 12/11/09.  He was released on 12/12/09.
Flu and Gardasil (1 dose of each) administered at 9:30am.  Between 2-3pm on same day experienced weakness, dizziness and hives with itching.  Hives were on face.  Also on Keflex for UTI.  Took Benadryl at home for hives.  4:45pm states she is still weak but no longer itching.
This spontaneous report was received from a pharmacist refers to a 54 year old male patient. Information regarding patient's pertinent medical history, drug reactions/allergies and concomitant medications were unknown. Approximately in November 2014, the patient was vaccinated with ZOSTAVAX (dosing details not provided) via subcutaneous route. Pharmacist reported that an unspecified amount of time after the dose was administered, the patient developed a rash at the injection site. Outcome of the event was reported as recovered. Reporting pharmacist had not assessed the causality of the event with respect to ZOSTAVAX. This is one of the two reports received from the same reporter. Additional information has been requested.
Syncope after leaving clinic; had fasting blood draw as well, had not yet eaten, only had 1 glass water entire morning. Observed event at a nursing home; briefly lightheaded then fell. Pacer interrogation showed 6 second run of VT at 120/min.
Patient was given an expired vaccine, vaccine expired at 1230pm, and was given at 210pm, patient was contacted and came in 3/5/21 to be revaccinated.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 75-year-old male patient who received SHINGRIX. On 23rd April 2018, the patient received SHINGRIX (intramuscular). On 25th April 2018, 2 days after receiving SHINGRIX, the patient experienced pain in arm. The patient was treated with TYLENOL. In April 2018, the outcome of the pain in arm was recovered/resolved. The reporter considered the pain in arm to be almost certainly related to SHINGRIX. Additional details were provided as follows: The patient reports arm pain, which began the next day after receiving a SHINGRIX injection in the left arm. The patient reports he took TYLENOL and the event resolved after one week.
Urticaria on trunk, extremities and face 6 days after receiving MMR/V.
I developed a systemic papular rash over the course of a few days covering my arms, legs, trunk, back.   It was sparse on my hands and feet but was present on both. It did not appear on my face or genitals.  It was extremely itchy and distressing.  The acute and widely disbursed rash is now gone but I'm still experiencing sporadic isolated appearance of rash in the same locations which are just as itchy and seem to come and go.  I have photos of the initial experience.  The rash was treated with 60MG of prednisone daily for 5 days and hydroxyzine as needed to help with the itching.  The worst of the rash began to recede after about day 3.  The current re-emergence of the rash is being managed with Clobex ointment as it appears.